IDO1 and depressive symptom measurement: Both human and animal studies have demonstrated that systemic administration of bacterial LPS increases cytokine levels, decreases positive moods, and induce depression-like symptoms [35,36,49]; in agreement, animal studies have revealed that administration of LPS induces Ido expression in different brain regions, resulting in depressive-like behaviors [50,51].